Royal Perth Hospital is a 450-bed adult and teaching hospital located on the northeastern edge of the central business district of Perth, Western Australia.

There are 450 beds in Royal Perth Hospital.

During the past decade, Royal Perth Hospital conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 59 clinical trials were completed, i.e. on average, 56.2% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 24 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Perth Hospital" #1 sponsor was "Gilead Sciences" with 26 trials, followed by "Trans Tasman Radiation Oncology Group" with 9 trials sponsored, "BeiGene" with 7 trials sponsored, "Celgene" with 7 trials sponsored and "Janssen Research & Development, LLC" with 7 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 132 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Perth Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 13 trials as a collaborator, "Abbott" with 5 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Breast International Group" with 4 trials as a collaborator. Other collaborators include 227 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "Royal Perth Hospital" are "Acute Myeloid Leukemia" (10 trials), "Breast Cancer" (9 trials), "Coronary Artery Disease" (8 trials), "Hypertension" (6 trials) and "Chronic Lymphocytic Leukemia" (5 trials). Many other conditions were trialed in "Royal Perth Hospital" in a lesser frequency.

Most popular intervention types in "Royal Perth Hospital" are "Drug" (181 trials), "Device" (29 trials), "Other" (23 trials), "Biological" (20 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Azacitidine" (6 trials), "Zanubrutinib" (6 trials), "Cytarabine" (5 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Royal Perth Hospital" are 231 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Perth Hospital". undefined are not yet recruiting, 44 are recruiting, 30 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 114 completed trials in Royal Perth Hospital, undefined suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Perth Hospital, 19 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 30 trials that are defined as “Not Applicable".